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CR3 (CD11b/CD18) and CR4 (CD11c/CD18) Are Involved
in Complement-Independent Antibody-Mediated
Phagocytosis of Cryptococcus neoformans
granulomatous inflammation with internalization of
yeast cells (reviewed in Casadevall and Perfect, 1998).
However, phagocytosis of C. neoformans cells can be
a formidable problem for host effector cells. C. neo-
formans cells are relatively large and are encased in
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Bronx, New York 10461 an antiphagocytic polysaccharide capsule that blocks
access of macrophage lectin receptors to yeast cell
wall mannans (Kozel, 1993; Kozel and Gotschlich, 1982).
Hence, phagocytic cells require C or Ab opsonins toSummary
ingest encapsulated C. neoformans cells. C-opsonized
C. neoformans can be ingested by various CRs (Levitz etIgM and IgA to the Cryptococcus neoformans capsular
glucuronoxylomannan (GXM) promote complement- al., 1997). During infection the problem of opsonization is
heightened by paucity of Ab to the capsular polysaccha-independent phagocytosis by macrophages with effi-
ciency comparable to that of IgG1. IgM- and IgA-medi- ride (Kozel et al., 1977) and depletion of C components
(Macher et al., 1978).ated phagocytosis of C. neoformans was proportional
to CR3 expression, inhibited by Abs to CR3 (CD11b/ IgM, IgG1, and IgA mAbs to the capsule of C. neo-
formans are protective in murine models of cryptococ-CD18) and CR4 (CD11c/CD18), and dramatically re-
duced with macrophages of CD18-deficient mice. IgM cosis (Mukherjee et al., 1992). Capsule binding Abs of
the IgM and IgA classes are common in human sera andand IgA promoted ingestion of yeast cells by CHO cells
expressing CR3 and CR4. In contrast, IgG1-mediated may be important in host defense (Deshaw and Pirofski,
1995; Fleuridor et al., 1999). Previously, we noted thatphagocytosis was only partially inhibited by Abs to
CR3 and CR4. Phagocytosis by IgM and IgA but not both IgM and IgA promote phagocytosis and killing of
yeast cells by J774.16 macrophage-like cells in mediaIgG1 was inhibited by soluble GXM, which binds CD18.
Involvement of CR in antibody-mediated complement- with heat-inactivated FCS, implying a C-independent
process (Mukherjee et al., 1995b). In this study, we inves-independent phagocytosis indicates a new link be-
tween innate and adaptive immune systems. tigated the mechanism by which IgM and IgA promoted
phagocytosis of C. neoformans in the absence of func-
tional C. The results indicate that Abs opsonize C. neo-Introduction
formans for ingestion by facilitating the interaction of
capsular polysaccharide with CR3 and CR4. Hence,IgM is the first antibody (Ab) class made in the adaptive
humoral response and comprises a large proportion of products of the adaptive immune response, namely Abs,
promote phagocytosis through a receptor of innate im-the Ab made in response to polysaccharide antigens.
Naturally occurring IgM constitutes a critically important munity by altering a microbial capsule.
early defense against microbial infection (Ochsenbein
and Zinkernagel, 2000). The classical view of IgM func- Results
tion is that it mediates opsonization of microorganisms
by activating the classical complement (C) pathway with IgM and IgA to the C. neoformans Capsule
consequent deposition of C3 on the microbial surface Are Opsonic in the Absence of C
followed by uptake through complement receptor 3 The polysaccharide capsule of C. neoformans prevents
(CR3, CD11b/CD18, m2). CR3 is an opsonic receptor phagocytosis of yeast cells in the absence of C or Ab
that recognizes C fragment C3bi deposited on the micro- opsonins (Kozel and Gotschlich, 1982; Kozel et al.,
bial surface. Two domains have been identified in the 1977). Previously, we reported that IgM and IgA to the
binding function of CR3 (reviewed in Ehlers, 2000). The C. neoformans GXM promoted phagocytosis by J774.16
I domain in CD11b binds ICAM-1, C3bi, fibrinogen, and macrophage-like cells in media that contained heat-
neutrophil inhibitory factor. The CD11b () subunit has inactivated FCS (Mukherjee et al., 1995b). This sug-
a lectin-like domain that recognizes mannose and gested a C-independent process, but the presence of
-glucans. Some fungi like Candida albicans may inter- heat-inactivated FCS in the media raised the possibility
act directly with both subunits of CR3 (Forsyth et al., that another serum constituent mediated the opsonic
1998) whereas others like Histoplasma capsulatum in- effect. Hence, our first task was to exclude an opsonic
teract with CD18 (Newman et al., 1990). effect from other serum proteins. Phagocytosis studies
Cryptococcus neoformans is a leading cause of me- using macrophages and macrophage-like cells in media
ningoencephalitis among patients with impaired immu- devoid of any FCS components established that IgM
nity, including those with AIDS (Mitchell and Perfect, and IgA were opsonic for C. neoformans without exoge-
1995). C. neoformans is a facultative intracellular patho- nous C components (Figure 1A). Multiple cell types were
gen in vivo and in vitro (Feldmesser et al., 2000a). Phago- studied to gain insight into the mechanism and the ex-
cytosis and intracellular killing are essential for the con- tent to which different phagocytic cells could engage in
trol of infection, and a successful host response involves this process. IgG1 was opsonic for all cell types. How-
ever, IgM and IgA promoted phagocytosis for peritoneal
macrophages but not for alveolar macrophages (Figure1Correspondence: casadeva@aecom.yu.edu
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1). In addition, both IgM and IgA promoted phagocytosis
for the J774.16 cells, but their opsonic efficacy for MH-S
cells was significantly lower (Figure 1). Since J774.16
and MH-S are derived from peritoneal and alveolar mac-
rophages, respectively, the opsonic efficacy of IgM and
IgA with these cells is similar to that observed with
primary macrophages. These experiments indicated dif-
ferences in phagocytic efficacy for IgM- and IgA-opso-
nized C. neoformans among macrophages of different
anatomic sites, a result consistent with a receptor-medi-
ated process.
However, there was still the possibility that phagocy-
tosis was proceeding through C3 produced by the mac-
rophages in vitro, as described for IgM-coated sheep
erythrocytes (Hetland and Eskeland, 1987). This mecha-
nism was excluded by demonstrating that IgM promoted
phagocytosis of C. neoformans for macrophages from
C3-deficient mice, in vitro and in vivo (Figure 2). No C3
was detected in sera of C3/-deficient mice or in the
capsule of C. neoformans cells ingested by macro-
phages from C3/ mice, thus ruling out a cryptic source
of C3 opsonin in these mice (data not shown). To confirm
that IgM- and IgA-opsonized C. neoformans was inter-
nalized, we examined macrophages-fungus suspen-
sions by scanning and transmission electron micros-
copy and confocal microscopy (Figure 3). All three
Figure 2. In Vitro and In Vivo Phagocytosis of C. neoformans bytechniques revealed that yeast cells were ingested after
Peritoneal Macrophages from C3-Deficient MiceIgM and IgA opsonization. Hence, we conclude that
(A) In vitro phagocytosis assay as a consequence of opsonizationmurine IgM and IgA are opsonic for C. neoformans in
with mAbs F(ab)2 fragment, 18B7 (IgG1), 12A1 (IgM), 13F1 (IgM), andthe absence of C.
no Ab. Phagocytosis experiment was performed in media devoid of
FCS or C components.
(B) In vivo phagocytosis at 2 hr for peritoneal macrophages fromKinetics of C. neoformans Phagocytosis
mice given mAb 18B7 (IgG1), 12A1 (IgM), 13F1 (IgM), or no Ab andTo gain insight into the biological relevance of C-inde-
infected with 107 yeast.pendent IgM- and IgA-mediated phagocytosis, we com-
Bars are the average of measurement from three wells (five fields
pared the efficiency of this process relative to IgG1. In each), and error bars denote SD. The percentage of macrophages
the absence of Ab or C, there was little or no phagocyto- with ingested C. neoformans cells is given in parenthesis. This ex-
periment was repeated three times on different days with similarsis. IgM alone was a more effective opsonin than C,
results. PI was determined as defined in the Experimental Proce-whereas IgG1 and IgM  C were comparable (Figure
dures.3D). After 120 min, the phagocytic index resulting from
IgM-mediated opsonization was 3-fold better than C
alone (Figure 3D). The kinetics of IgA-mediated phago- charides, and lectins (see Experimental Procedures)
cytosis was very similar to the IgM-mediated (data not were tested for their ability to inhibit IgM-mediated
shown). Hence, IgM and IgA are efficient opsonins for phagocytosis, but none inhibited this process (data not
C. neoformans in the absence of C. shown). The lectins of Bandeiraea simplicifolia and Da-
tura stramonium interfered with phagocytosis but they
also agglutinated yeast cells which could have pre-Effects of Monosaccharides, Polysaccharides, and
Lectins on IgA- and IgM-Mediated Phagocytosis vented uptake on basis of creating large clumps. In
contrast, the addition of C. neoformans capsular GXMTo identify the receptor for C-independent IgM- and IgA-
mediated phagocytosis, we studied substances known (100 g/ml) to J774.16 cells significantly inhibited IgM-
and IgA-mediated phagocytosis but not IgG1-mediatedto inhibit specific receptors for their ability to interfere
with this process. Several monosaccharides, polysac- phagocytosis. This concentration of GXM is lower than
Figure 1. Phagocytosis and Expression of CR3 from J774.16 Cells, Peritoneal Macrophages, MH-S Cells, and Alveolar Macrophages
Phagocytosis of C. neoformans by J774.16 cells (A), peritoneal macrophages (B), MH-S cells (C), alveolar macrophages (D), and peritoneal
macrophages from B6.129S7-Itgb2tm2Bay homozygote and heterozygote (E) as a consequence of opsonization with either 12A1 (IgM), 18B7
(IgG1), 7D8 (IgA), or no Ab. Phagocytosis experiment was performed in media devoid of FCS or C components. Bars are the average of
measurement from three wells (five fields each), and error bars denote SD. The percentage of macrophages with ingested C. neoformans
cells is given in parenthesis. This experiment was repeated three times on different days with similar results, except with CD18/. PI was
determined as defined in the Experimental Procedures. The right column shows expression of CR3 on J774.16 cells (A), peritoneal macrophages
(B), MH-S cells (C), alveolar macrophages (D), and CD18 expression on CD18/ mice (E), determined by FACS. Filled and dotted histograms
denote cells incubated with FITC-labeled Ab to CD11b or CD18. Open histograms denote cells incubated with irrelevant FITC-labeled Ab
used as a negative control.
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Figure 3. Phagocytosis and Kinetics Mediated by mAbs and Complement
(A) Scanning electron microscopy of yeast cells opsonized by mAb 12A1 and J774.16 macrophage-like cells activated with IFN- and LPS.
Bar denotes 10 m.
(B) Confocal microscopy of C. neoformans being phagocytosed by a J774.16 cell. The C. neoformans cells have been coated with mAb 12A1
followed by TRITC-labeled anti-mouse IgM. Macrophages were incubated with rat anti-mouse CR3, and their binding was detected using
Alexia 488-labeled goat anti-rat IgG. Bar denotes 10 m.
(C) Transmission electron microscopy of C. neoformans cells ingested by J774.16 cells after opsonization with mAb 12A1. Bar denotes 1 m.
(D) Phagocytosis of C. neoformans by peritoneal macrophages as a function of time after opsonization by mAb 18B7 (IgG1), 12A1 (IgM), C,
12A1  C, or dilutant alone (control). Each point in the curve is the average of measurement from three wells (five fields each), and error bars
denote SD. This experiment was repeated three times on different days with similar results. PI was determined as defined in the Experimental
Procedures.
(E) Regression analysis of CR3 expression and percentage of macrophages with ingested yeast.
that found in C. neoformans-infected organs (Fries et Effects of Abs to Cell Surface Determinants
on IgM- and IgA-Mediated Phagocytosisal., 2001) and hence is physiologically relevant. IgM-
and IgA-mediated phagocytosis was inhibited by GXM Since CD14 is an opsonic receptor for gram-negative
bacteria (Grunwald et al., 1996), we examined whetherby 58% and 39%, respectively (p  0.05 for both com-
parisons). Similar results were obtained with peritoneal Ab to CD14 inhibited IgM-mediated phagocytosis but
found no effect (data not shown). However, additionmacrophages (data not shown).
of Abs to CD11b and CD18 significantly reduced the
opsonic efficacy of IgM and IgA mAbs but had only a
 Potential small effect on IgG1-mediated phagocytosis. CR3 is a
We considered that IgM-mediated phagocytosis was a potential site of interaction between the fungus and the
result of changes in cell charge. C. neoformans cells macrophages because GXM can bind to CD18 (Dong
are highly negatively charged as a consequence of their and Murphy, 1997). Involvement of CR4 (CD11c/CD18)
polysaccharide capsule, and IgG1 binding can increase in this process was suggested by the observation that
the magnitude of the cell charge (Nosanchuk and Casa- addition of Abs to CD11b, CD11c, and CD18 almost
completely abolished the opsonic efficacy of the IgMdevall, 1997). However, binding of mAb 12A1 to C. neo-
formans produced no consistent change in cellular and IgA mAb (Figure 4A). These results implicated CR3
and CR4 in IgM-and IgA-mediated phagocytosis andcharge (data not shown).
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Figure 4. Phagocytosis of IgM-, IgA-, or IgG1-Opsonized C. neoformans and Expression of CR3 and CR4 by J774.16 Cells and Jaws II Cells
J774.16 cells (A) or Jaws II (B) in the presence of Abs to CD18, CD11b, and CD11c. Phagocytosis experiment was performed in media devoid
of FCS or C components. Bars are the average of measurement from three wells (five fields each), and error bars denote SD. The percentage
of macrophages with ingested C. neoformans cells in the control group is given in parenthesis. This experiment was repeated three times on
different days with similar results. Asterisks denote statistical significance in the phagocytic index p  0.05. PI was determined as defined in
the Experimental Procedures. Expression of CR3 and CR4 on J774.16 cells (A) and Jaws II cells (B), as determined by FACS. Filled histograms
denote cells incubated with irrelevant FITC-labeled goat anti-mouse Ab. Open histograms denote cells incubated with FITC-labeled Abs to
CD11b and CD11c as marked. The magnitude of the phagocytic index for Jaws II cells was three to four times that of J774.16 which, combined
with high receptor expression, probably accounts for the absence of statistically significant inhibition of IgG1-mediated phagocytosis by Abs
to CD11b and CD11c.
suggested involvement of CR in ingestion of some frac- would behave in a manner similar to IgM and IgA. As
tion of IgG1-opsonized C. neoformans cells. However, hypothesized, F(ab)2 fragments to GXM were opsonic
since CR4 is a dendritic cell marker and FACS analysis for peritoneal macrophages and J774.16 cells but not for
of J774.16 did not reveal detectable CR4 (see below), alveolar macrophages or MH-S cells. F(ab)2 fragments
we repeated the phagocytic studies using Jaws II, a were also opsonic for peritoneal macrophages from C3-
dendritic cell line known to express CR3 and CR4. The deficient mice (Figure 2). The phagocytosis index of
results with Jaws II cells are similar to those obtained J774.16 cells for F(ab)2-opsonized C. neoformans was
with J774.16 and peritoneal macrophages and provide 28	 7.07. F(ab)2 phagocytic efficacy was reduced 78%
further evidence of CR3 and CR4 involvement (Fig- and 86% by Abs to CD11b and CD18, respectively. Com-
ure 4B). bining Abs to CD11b and CD18 reduced the opsonic
efficacy of F(ab)2 almost completely. Similar results
were obtained with peritoneal macrophages and JawsOpsonization of C. neoformans by F(ab)2 Fragments
II cells (data not shown). Scanning electron microscopyThe fact that soluble GXM binds CD18 in the soluble
of F(ab)2 bound to C. neoformans revealed changes inform but is antiphagocytic in capsule form suggested
the capsule of C. neoformans similar to those describedthat opsonization by IgM and IgA was the result of a
previously with mAb 12A1 (Cleare and Casadevall, 1999)conformational change in the capsule that allowed the
(data not shown). Hence, F(ab)2 fragments behave likeinteraction of GXM with CR3 and CR4. If this were true,
IgM and IgA with regard to promoting C-independentwe hypothesized that F(ab)2 fragments with specificity
for GXM would also be opsonic for C. neoformans and phagocytosis of C. neoformans. The opsonic efficacy
Immunity
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of F(ab)2 fragments to GXM excluded a contribution
from Ab Fc regions and suggested a mechanism involv-
ing a change in the capsular structure.
Opsonic Efficacy of IgM, IgA, and IgG1 for
C. neoformans with CD18-Deficient Macrophages
To confirm involvement of CD18, we studied phagocyto-
sis of IgM- and IgA-opsonized C. neoformans with peri-
toneal macrophages from CD18-deficient and CD18/
mice. IgM- and IgA-mediated phagocytosis, but not
IgG1, was reduced by 50% for CD18-deficient mice
(data not shown). For CD18/macrophages the efficacy
of IgM- and IgA-mediated phagocytosis was about 20%
of that observed for wild-type mice (Figure 1E). Figure 5. Phagocytosis Mediated by CHO Cells
Opsonization of C. neoformans by IgM (12A1), IgA (7D8), IgG1
(18B7), and F(ab)2 for CHO cells expressing LFA-1, CR3, CR4, orThe Efficacy of C-Independent IgM- and IgA-Mediated
no receptor. The phagocytosis experiment was performed in mediaPhagocytosis Correlates with CR Expression
devoid of FCS or C components. Bars are the average of measure-The result that Abs to CD11 and CD18 inhibited IgM-
ment from three wells (five fields each), and error bars denote SD.and IgA-mediated phagocytosis and the results with
The percentage of CHO with ingested or attached C. neoformans
CD18-deficient macrophages suggested that the differ- cells is given in parenthesis. This experiment was repeated three
ences in phagocytic efficacy between peritoneal, alveo- times on different days with similar results. The phagocytosis index
was determined as defined in the Experimental Procedures.lar, MH-S, and J774.16 cells (Figure 1) were due to differ-
ences in CR3 expression. FACS analysis revealed
significantly less CR3 receptor in alveolar macrophages
and MH-S cells than in peritoneal macrophages and 12A1 was opsonic for both serotype A (PI 
 39 	 2.1)
and D (PI 
 50.7 	 4.5) strains, and phagocytosis wasJ774.16 cells (Figure 1). Hence, the phagocytic efficacy
of the cell type for IgM- and IgA-mediated C-indepen- reduced by 62% and 46% by Ab to CD11b, respectively,
and 44% and 52% by Ab CD18, respectively. In contrast,dent phagocytosis of C. neoformans correlated with
CR3 expression. The observation that Ab to CD11c also MAb 13F1 was opsonic only for the serotype A (PI 

33 	 2.8), and phagocytosis was reduced by 68% byinterfered with phagocytosis implied involvement of CR4
in this process. Both CR3 and CR4 were detected in Ab to CD11b and 49.4% by Ab to CD18. When both Abs
to both CD11b and CD18 were added, phagocytosisJaws II cells. However, for J774.16 there was minimal
or no detection of CR4 with the reagents used (Figure was reduced 90%. The results with the IgM MAb 13F1
provide an important control because they confirm that4). The results obtained with the various cell types re-
vealed a highly significant correlation between CR3 ex- the process can occur with another IgM and demon-
strate that the Ab must bind to a particular antigenicpression and IgM-mediated phagocytic efficacy (p 

0.005) (Figure 3E). determinant on the capsule to be opsonic.
Phagocytic Activity of CHO Cells ExpressingOpsonization of Serotypes A and D by mAbs
LFA-1, CR3, and CR4 Receptors12A1 and 13F1
Despite strong evidence that IgM- and IgA-mediatedGiven the surprising observation that CR3 and CR4 were
C-independent phagocytosis involved CR3 and CR4, weinvolved in IgM-mediated C-independent phagocytosis,
sought to confirm this finding in another system. Hence,we sought to confirm the result with another IgM and
we studied the opsonic efficacy of IgM, IgA, IgG1, andto identify a situation that provided a positive and a
F(ab)2 mAbs for CHO cells expressing LFA-1, CR3, ornegative control. By investigating IgM opsonization for
CR4 receptors (Figure 5). IgM and IgA opsonized C.another C. neoformans serotype and by evaluating a
neoformans cells for attachment and ingestion of CHOsecond IgM mAb known as 13F1, we were able to con-
cells expressing CR3 and CR4 but not for those express-firm the results and establish that only certain types of
ing LFA-1 or no C receptor (CHO-neo). Similar resultsAb binding produced this effect. MAb 12A1 (the IgM
were obtained with IgG or F(ab)2, but their activity wasused primarily in this study) produces annular immu-
lower than IgM or IgA (Figure 5). These results confirmnofluorescence pattern upon binding C. neoformans
the involvement of CR3 and CR4 in C-independent IgM-strains of serotypes A and D and is opsonic for both
and IgA-mediated phagocytosis of C. neoformans im-(Cleare and Casadevall, 1998). In contrast, mAb 13F1
plied by the inhibition studies with Abs to CR.produces annular and punctate immunofluorescence
patterns with serotypes A and D, respectively, but is
opsonic only for serotype A strains (Cleare and Casade- Effect of Abs to IgG Fc Domain on Opsonic Efficacy
Based on the observation that yeast cells opsonized byvall, 1998). This is apparent in Figure 2, which shows
that mAb 12A1 is a significantly more effective opsonin F(ab)2 fragments to GXM were ingested by macro-
phages, we hypothesized that IgG could opsonize C.for serotype D cells than mAb 13F1. Since mAbs 12A1
and 13F1 differ in fine specificity, we evaluated whether neoformans for phagocytosis involving either FcR or
CR3. We reasoned that if this were the case, then Absthe opsonic characteristics of mAb 13F1 for serotype A
and D strains corresponded to that of mAb 12A1 with to the FcR domains of IgG would not be able to inhibit
phagocytosis unless CR3 was also blocked. For theseregard to inhibition by Abs to CD11b and CD18. MAb
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strongly against a nonspecific opsonic effect and sug-
gested a receptor-mediated process. For IgM, the Fc
receptors have been reported, but their existence and/
or function is uncertain (Medgyesi et al., 1984; Uher et
al., 1981). For IgA, an Fc receptor has been described
in certain macrophage cells, but its action appears to
require collaboration from CR3 activated by C (van Eg-
mond et al., 2001). Recently, an Fc/R was described
(Shibuya et al., 2000) but is not responsible for our results
since we were unable to detect mRNA expression in
cell types that avidly ingested IgM- and IgA-opsonized
C. neoformans such as J774 (our unpublished data).
Furthermore, rabbit polyclonal sera to a peptide with
receptor sequence did not inhibit IgM- and IgA-medi-
ated phagocytosis (our unpublished data). Hence, in our
system, C-independent IgM- and IgA-mediated phago-
cytosis of C. neoformans occurs primarily by a mecha-
nism that can be explained without invoking a role for
Fc/R, although we do not exclude that Fc/R can
collaborate with CR3 in certain situations.
Our initial approach was to determine whether inhibi-
tors of known phagocytic receptors inhibited phagocy-
tosis. Addition of D-mannose, D-fucose, mannan, or de-
xtran had no effect on phagocytosis, indicating thatFigure 6. Blocking of CR3 and Fc Portion of IgG1 Inhibits Phagocy-
tosis neither the mannose-fucose or scavenger receptors
Phagocytosis of C. neoformans by J774.16 (A) or MH-S (B) cells were likely to be involved in this process. Similarly, our
after opsonization with mAb 18B7 in the presence of Abs to IgG Fc inability to inhibit the process with Abs to CD14 argued
region or CR3. Phagocytosis experiment was performed in media against CD14-mediated phagocytosis as described for
devoid of FCS or C components. The percentage of macrophages
some gram-negative bacteria. A variety of lectins werewith ingested C. neoformans cells is given in parenthesis. Bars are
evaluated for their ability to inhibit phagocytosis, but thethe average of measurement from three wells (five fields each), and
only inhibition was observed with lectins that promotederror bars denote SD. This experiment was repeated three times on
different days with similar results. PI was determined as defined in agglutination of fungal cells. Since agglutination could
the Experimental Procedures. have interfered with phagocytosis, the reduction in
phagocytosis observed with agglutinating lectins can-
not be attributed to a specific inhibition mechanism. In
experiments, we used F(ab)2 fragments to the IgG Fc contrast, addition of soluble C. neoformans capsular
domain to avoid the problem of having an intact Ab Fc GXM inhibited IgM- and IgA-mediated phagocytosis but
region that would have allowed phagocytosis through not IgG1 opsonization. Since GXM can bind CD18 (Dong
FcR. F(ab)2 fragments to the IgG Fc domain blocked and Murphy, 1997), this observation suggested the
phagocytosis of MH-S cells (Figure 6B) but not J774.16 involvement of the family of CD18-containing surface
cells (Figure 6A). However, concomitant addition of Abs receptors in this process.
to the IgG Fc domain and CR3 significantly reduced LFA1, CR3, and CR4 are composed of CD18 in combi-
nation with CD11a, CD11b, and CD11c, respectively. Inphagocytosis by J774.16 cells. This result indicates
the presence of Ab to CD18, the phagocytic indicesinvolvement of FcR and CR3 in IgG1-mediated phagocy-
resulting from incubation of IgM- and IgA-coated C.tosis for J774.16 cells, whereas MH-S (which lacks CR)
neoformans with peritoneal macrophages or J774.16exhibited IgG1-mediated phagocytosis only through
macrophages were reduced. Ab to either CD11a orFcR. Figure 7 shows a proposed mechanism by which
CD11c to the macrophage-C. neoformans suspensionsIgM, IgG (total or F(ab)2 fragment), and IgA opsonize C.
had no effect on phagocytic index but Ab to CD11bneoformans in the absence of C.
significantly reduced phagocytosis. However, it appears
that the lectin site in CD11b is not involved since neither
Discussion N-acetyl glucosamine nor soluble -glucan laminarin
inhibited phagocytosis. These polymers are known to
The efficiency of IgM- and IgA-mediated C-independent bind to the lectin domain of CR3 (Brown and Gordon,
phagocytosis was dependent on the type of macro- 2001; Czop and Austen, 1985). Combining Abs to CD18
phage used, with peritoneal macrophages exhibiting and CD11b reduced phagocytosis by over 70%, impli-
significantly greater activity than alveolar macrophages. cating CR3 in the process of IgM- and IgA-mediated
Similarly, J774.16 cells derived from a peritoneal sar- phagocytosis. Adding Abs to CD18, CD11b, and CD11c
coma and Jaws II dendritic-like cells derived from bone virtually eliminated the opsonic efficacy of both IgM
morrow cells were efficient phagocytic cells for IgM- and IgA, implicating CR4 in this phagocytic process.
and IgA-coated C. neoformans cells. In contrast, MH-S Phagocytosis involving CR3 was consistent with the ob-
cells derived from alveolar macrophages exhibited sig- servation that IgM and IgA are opsonic for peritoneal
nificantly less phagocytosis. The occurrence of phago- but not alveolar macrophages since the latter expressed
only low levels of CR3. CHO cells expressing LFA1, CR3,cytosis in only certain macrophage cell types argued
Immunity
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Figure 7. Schematic Summary of Proposed Mechanism
Mechanism for the ingestion of C. neoformans by macrophages after opsonization with IgM, IgG1, IgA, and F(ab)2 fragments in the absence
of C. We hypothesize that IgM, IgG, IgA, or F(ab)2 bind to the cryptococcal capsule and cause a structural change that exposes the CD18
binding domain in GXM. The antibody-altered capsular polysaccharide can then interact directly with CR3. IgM-, IgA-, and F(ab)2-mediated
phagocytosis is able to utilize CR3 and CR4; however, IgG-mediated phagocytosis is able to use both CR3/CR4 and FCR.
and CR4 were used to validate these observations. IgM express both CR3 and CR4. Blocking of either receptor
resulted in modest reductions in phagocytosis whereasand IgA promoted phagocytosis of C. neoformans in
cells expressing CR3 and CR4 but not LFA1. Similarly, simultaneous blocking of both receptors resulted in sig-
nificant reduction in ingested yeast. Consistent withIgM and IgA were not opsonic for CHO-neo cells used
as controls. IgG and F(ab)2-coated C. neoformans cells their dendritic cell origin, Jaws II cells were generally
more active than J774.16 cells with regard to phagocy-were poorly ingested by CHO cells expressing CR3 and
CR4 despite the fact that these receptors appear in- tosis.
Since CD18 can bind GXM (Dong and Murphy, 1997),volved in F(ab)2-mediated phagocytosis by murine mac-
rophages. This observation may be explained by differ- we considered that IgM- and IgA-mediated phagocyto-
sis reflected facilitated binding of capsular polysaccha-ences in receptor density, species differences, and/or
the type of capsule changes mediated by intact ride by CR3 and CR4 as a consequence of Ab binding
to the capsule. In this regard, scanning EM micrographAbs and their fragments. The CHO cell data confirms
that IgM- and IgA-mediated phagocytosis can occur of C. neoformans cells coated with Ab suggests major
changes in the capsular structure (Cleare and Casade-through a C-independent mechanism that involves CR3
and CR4. vall, 1999; Mukherjee et al., 1995a) which could poten-
tially neutralize the intrinsic antiphagocytic propertiesInvolvement of CD18 in C-independent IgM- and IgA-
mediated phagocytosis was conclusively established of the capsule by exposing polysaccharide motifs that
can interact with macrophage receptors. To investigateby demonstrating a dramatic reduction in phagocytic
efficacy when IgM- and IgA-opsonized C. neoformans this possibility, we evaluated the opsonic efficacy of
F(ab)2 fragments to GXM and found that they were com-were added to CD18-deficient macrophages. Further-
more, an excellent correlation was observed between parable to IgM and IgA. This finding was surprising be-
cause F(ab)2 fragments-mediated opsonization of mi-the phagocytic efficacy of the macrophage type for
IgM-/IgA-opsonized C. neoformans and the expression crobes usually occurs by promoting activation of the
alternative C pathway, yet our assay was carried out inof CR3. To confirm involvement of CR4 in C-independent
IgM- and IgA-mediated phagocytosis, we used the Jaws conditions devoid of C (Sedlacek et al., 1983). F(ab)2-
mediated phagocytosis of C. neoformans paralleled thatII dendritic cell line. This line was demonstrated here to
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observed for IgM and IgA with regard to its efficiency nation based on location of antibody binding to the cap-
for peritoneal and alveolar macrophages and was com- sule is unlikely since both mAb 12A1 and 13F1 bind near
pletely inhibited by Ab to CD11b and CD18. These obser- the capsular surface (Feldmesser et al., 2000b) and both
vations strongly suggest that IgM, IgA, and F(ab)2 each should, in theory, interact with cellular receptors if the
promote phagocytosis of C. neoformans by the same mechanism of phagocytosis were based on direct IgM-
mechanism. Since F(ab)2 fragments lack the Fc region receptor interactions. However, mAbs 12A1 and 13F1
and IgM is opsonic for FcR/ macrophages, we con- form different types of complexes with the C. neo-
clude that this process is not dependent on FcR re- formans capsule as indicated by light and electron mi-
ceptors. croscopy (Feldmesser et al., 2000b). Differences in the
In most experiments, we noted some reduction in appearance of the capsule by scanning electron micros-
phagocytic index of IgG1-opsonized C. neoformans copy after binding mAbs 12A1 and 13F1 (Cleare and
after addition of Abs to CD18, CD11b, and CD11c. If Casadevall, 1999) strongly suggest that these IgM mAbs
IgG1-mediated phagocytosis proceeds exclusively through produce different capsular structural changes as a con-
FcR, one should not have expected any diminution sequence of binding. Other evidence indicative of differ-
in opsonic efficacy. Instead, this result suggested that ences in Ab-capsule structure following binding by
IgG1, like IgM and IgA, induced structural changes upon mAbs 12A1 and 13F1 are qualitative differences in the
binding to the C. neoformans capsule that promoted capsular reactions and the ability of the capsule to acti-
ingestion by CR3 and CR4. This mechanism was con- vate the alternative C pathway (MacGill et al., 2000). The
firmed by demonstrating that blocking the IgG1 Fc por- IgM mAb 13F1 to promote phagocytosis of serotype D
tion with specific F(ab)2 abrogated IgG1-mediated strains provides an important control for these experi-
phagocytosis by MS-H cells (which express FcR but ments because it shows that only certain types of IgM
little CR3). However, inhibition of IgG1-mediated phago- interactions with the capsule result in opsonization.
cytosis for J774.16 cells (which express both FcR and C-independent Ab-mediated phagocytosis through
CR3) required blocking of both the IgG1 Fc portion and CR3 is likely to be a biologically relevant process. First,
CR with Abs to CD11b and CD18. C-independent IgM-mediated phagocytosis indicates a
Our data can best be interpreted by a model where- more efficient process than C-mediated phagocytosis.
by IgM, IgG1, IgA, and F(ab)2 fragments bind to the Thus, phagocytosis may proceed by this receptor even
C. neoformans capsule and induce a conformational in the presence of C. Second, cryptococcosis results
change that exposes the CD18 binding site in capsular in acquired C deficiency as a result of depletion of C
GXM, such that it can bind CR, as has been reported for components, which means that IgM bound to the cap-
soluble GXM (Dong et al., 1998). The direct interaction of sule would have to act alone as an opsonin (Macher et
capsular polysaccharide with CR3, and possibly CR4, al., 1978). Third, C. neoformans infection often involves
would then trigger phagocytosis. Support for this mech- body compartments devoid of C such as the alveolar
anism comes from the observation that soluble GXM and meningeal spaces where IgM and IgA can be pres-
inhibited IgM- and IgA-mediated phagocytosis but had ent as a result of local production. In this regard, B cells
only a minor effect on IgG1-mediated phagocytosis, are the predominant cell type in lung infiltrate providing
which can also proceed through FcR. Since the intact a source of local immunologlobulins (Feldmesser et al.,
capsule is antiphagocytic, yet soluble GXM and other 2002), and in the brain there is an intrathecal Ab re-
capsular components can bind to CR3, one can surmise sponse (La Mantia et al., 1986). Fourth, IgM administra-
that the polysaccharide motifs that interact with this tion reduces fungal burden lacking C3 (our unpublished
receptor are not exposed in the native capsule structure. data). In aggregate, the efficiency of C-independent Ab-
The same mechanism may apply to other microorgan- mediated phagocytosis through CR3, combined with
isms with antiphagocytic polysaccharide capsules and the unusual characteristics of this infection, provides a
may explain the observation that F(ab)2 fragments of compelling case that this mechanism of phagocytosis
antipneumococcal antibodies protected against experi-
is important for host defense.
mental Streptococcus pneumoniae infection (Ramisse
et al., 1996). Experimental Procedures
Phagocytosis involving CR3 and/or CR4 as a conse-
quence of an Ab-mediated alteration in the capsular mAbs
structure suggests an explanation for the observation Aseites were generated in Balb/c mice given i.p. injection of mAb-
producing hybridomas. IgM and IgA mAbs were first precipitatedthat only certain IgMs to GXM are opsonic for C. neo-
with ammonium sulfate and then purified by size exclusion usingformans. IgM binding to the C. neoformans capsule in
HiPrep Sephacryl S-300 high resolution (HR26/60) gel (Pharmaciaan annular IF pattern is associated with opsonic efficacy
Biotech, Uppsala, Sweden) equilibrated with endotoxin-free PBS.
(Cleare and Casadevall, 1998). The IgM MAb 13F1 pro- The protein separation was monitored by UV, and the fractions
duces annular and punctate immunofluorescence (IF) containing IgM and IgA were identified by ELISA. The IgM mAbs
patterns upon binding to serotype A and D strains, re- were also purified by affinity chromatography with a mannan binding
spectively, whereas the IgM mAb 12A1 produces annu- protein column (Pierce, Rockford, IL) as per the manufacturer’s in-
structions. The IgG1 was purified by protein A affinity chromatogra-lar patterns on both serotypes (Cleare and Casadevall,
phy (Pierce, Rockford, IL) as per the manufacturer’s instructions.1998; Nussbaum et al., 1997). MAb 13F1 is not opsonic
The following mAbs with specificity for GXM have been described:for serotype D strains despite being an effective opsonin
12A1 and 13F1, IgM; 7D8, IgA; and 18B7, IgG1 (Casadevall et al.,
for serotype A strains, whereas mAb 12A1 is an effective 1992). Antibodies to mouse CD14 (clone rmC5-3, rat [LOU] IgG1,),
opsonin for both serotypes (Cleare and Casadevall, CD18 (clone M18/2, rat IgG2a,), CD11a (clone M17/4, rat [Wistar/
1998). The inability of mAb 13F1 to promote opsoniza- Furth] IgG2a,), CD11b (clone M1/70, rat [DA] IgG2b,), and CD11c
(clone HL3, Armenian hamster IgG, group 1, ) were obtained fromtion for serotype D strains is not understood. An expla-
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BD Pharmingen, San Diego, CA. Murine IgG1, from MOPC-21 (BD by the addition of 2 M H2SO4, and the absorbance at 492 nm was
measured in a Labsystem multiscan reader (Labsystem, Helsinki,Pharmingen, San Diego, CA) was used as an isotype-matched stan-
dard. Antibodies were added before or during phagocytosis assay Finland). For immunofluorescence, either yeast incubated with
straight fresh serum or yeast recovered from the peritoneal lavageat concentrations of 0.1, 1, 5, and 10 g/ml. Anti-mouse IgG (Fc
specific, goat F(ab)2 fragment) from Sigma (Saint Louis, MO) was after 2 hr was incubated with goat anti-mouse C3 (Cappel, Aurora,
OH), followed by incubation with FITC-labeled rabbit anti-goatused at 100 to 200 g/ml.
(Southern Biotechnology, Birmingham, AL), and placed on a glass
slide. The slides were examined using an Olympus IX 70 microscopePreparation of F(ab)2 Fragments from IgG mAb 18B7
(Olympus America, Melville, NY). As a positive control, we used freshF(ab)2 fragments were prepared using a commercial kit (Immuno-
serum or yeast recovered from peritoneal lavage from C57Bl/6.Pure, Pierce, Rockford, IL), as per the manufacturer’s instructions.
The purity of F(ab)2 fragments was assessed by SDS-PAGE, fol-
lowed by silver staining, and no intact IgG was detectable. Phagocytosis Assay
Peritoneal and alveolar macrophages and macrophage-like cells
from the J774.16 and MH-S cell lines with 10% heat-inactivatedC. neoformans
FCS were cultured in Dulbecco’s Modified Eagle medium, 10%Strain 24067 (serotype D) was obtained from the American Type
NCTC-109 medium, and 1% nonessential amino acids. Jaws II cellsCulture Collection (Manassas, VA). Strain H99 (serotype A) was ob-
were maintained in  minimum essential medium with 20% heat-tained from Dr. John Perfect (Durham, NC). C. neoformans cultures
inactivated FCS and 10 ng/ml of mrGM-CSF (Genzyme, Cambridge,were grown in Sabouraud dextrose broth at 30C overnight with
MA). Our phagocytosis assays were done as described in our priormoderate shaking (150 rpm). Yeast cells were washed three times in
studies with minor modifications (Mukherjee et al., 1995b, 1996;PBS, then suspended in PBS, and counted using a hemocytometer.
Taborda and Casadevall, 2001). In brief, macrophages were plated
at a density of 105 cells per well in a 96-well culture plate andCell Lines
stimulated with recombinant murine  interferon (IFN-) overnightThe macrophage-like cell lines J774.16 and MH-S and the dendritic
and lipopolysaccharide (LPS) for 1 hr after overnight incubation.cell line Jaws II were used for some phagocytosis studies. The
Macrophages were primed with IFN- and LPS to provide a moreJ774.16 cell line is derived from a reticulum cell sarcoma (Ralph et
sensitive system. Phagocytosis was measured in media with andal., 1975) and has been used extensively to study C. neoformans-
without fetal calf serum in the presence and absence of GXM bindingmacrophage interactions (Mukherjee et al., 1996). The MH-S cell line
antibodies. C. neoformans cells were added at an effector to targetoriginates from SV40 transformation of an adherent cell-enriched
ratio of 1:5, and the suspension was incubated at 37C for 2 hr. Thepopulation of alveolar macrophages (Mbawuike and Herscowitz,
macrophage monolayer was then washed several times with sterile1989). J774.16 and MH-S cells were cultured in DME with 10%
PBS, fixed with cold absolute methanol, and stained with 1:20 solu-heat-inactivated fetal calf serum, 10% NCTC-109 medium, and 1%
tion of Giemsa. The phagocytic index was determined by micro-nonessential amino acids. Jaws II is an immortalized bone marrow-
scopic examination at a magnification of 600. For each experiment,derived dendritic cell line from a C57Bl/6 mouse. Jaws II cells were
five fields in each well were counted, and at least 200 macrophagescultured in  minimum essential medium (Gibco, Grand Island, NY)
were analyzed in each well. All conditions were tested in triplicate.with 20% FCS and 10 ng/ml mrGM-CSF (Genzyme, Cambridge, MA).
The phagocytic index is the percentage of macrophages with inter-CHO cell lines stably transfected with LFA-1 (CD18/CD11a), CR3
nalized yeast cells times the average number of internalized yeast(CD18/CD11b), and CR4 (CD18/CD11c) were obtained from Dr.
cells, as defined in classical studies of phagocytosis (Bianco et al.,Douglas T. Golenbock (Boston Medical Center, Boston, MA). CHO
1975). Inhibitors of phagocytosis were added before or concomi-cell lines were cultured in  minimum essential medium with 10%
tantly with the addition of fungi and mAbs.heat-inactivated fetal calf serum.
In Vivo PhagocytosisMice and Primary Macrophages
C57Bl/6 C3-deficient mice were given either mAbs 12A1, 13F1,Alveolar and peritoneal macrophages were isolated from mice killed
18B7, or PBS i.p. 5 min before infection with 107 yeast cells. Thein accordance with the euthanasia policy of Animal Institute of Albert
assay was performed as described before (Taborda and Casadevall,Einstein College of Medicine. Balb/c mice (6–8 weeks) were obtained
2001).from the National Cancer Institute (Frederick, MD) and Jackson
Laboratories (Bar Harbor, ME). C57Bl/6 C3-deficient mice were do-
Carbohydrates, Polysaccharides, and Lectinsnated by Dr. Matthew D. Scharff (Albert Einstein College of Medicine)
The effect of various carbohydrates, polysaccharides, and lectinsand were originally obtained from Dr. Michael Carroll (Boston, MA).
on phagocytosis was studied. D-mannose, D-galactose, D-gluronicB6.129S7-Itgb2tm1Bay (CD18-deficient), B6.129S7-Itgb2tm2bay homozy-
acid lactone, and D-xylose (Sigma, St. Louis, MO) were used atgote and heterozygote (CD18/), and C57Bl/6J mice were obtained
concentrations ranging from 10 to 300 mM. Mannan (Sigma, St.from Jackson Laboratories (Bar Harbor, ME). For alveolar macro-
Louis, MO) was used at 1, 10, and 100 g/ml. Soluble -glucanphage isolation, the trachea was exposed by a skin incision, and a
laminarin (Sigma, St. Louis, MO) was used at 10, 100, and 50020 gauge angiocath (Becton Dickinson, Sandy, UT) was advanced
g/ml. The lectins Abrus precatorious, Agaricus bisporus, Anguilla3 mm into the trachea and sutured in place. The lungs were then
anguilla, Arachis hypogaea, Artocarpus integrifolia, Bandeiraea sim-lavaged ten times through the catheter with sterile calcium and
plicifolia, Cicer arietinum, Codium fragile, Concanavalin A, Daturamagnesium-free HBSS without phenol red (Life Technologies, Grand
stramonium, Erythrina corallodendron, Euonymus europaeus, Ga-Island, NY) using 0.8 ml per wash. From the same mice, peritoneal
lanthus nivalis, Limulus polyphemus, Lycopersicon esculentum,macrophages were collected by lavaging the abdominal cavity five
Maackia amurensis, Narcissus pseudonarcissus, Phaseolus vul-times with sterile HBSS using a Pasteur pipette.
garis, Pisum sativum, Tetragonolobus purpureas, and Viscum album
(Sigma, St. Louis, MO) were used at concentrations ranging fromComplement Assays
100 to 0.5 g/ml. C. neoformans GXM was prepared as describedTo validate the absence of C in C3/ mice, we measured the pres-
(Cherniak et al., 1982).ence of C3 in serum and in the capsule of macrophage-ingested
yeast cells. Serum C3 was measured by capture ELISA whereby
polystyrene plates (Falcon) were first coated with goat anti-mouse Inhibition of Phagocytosis by Addition of Ab to Ig Fc Domain
Approximately 106 strain 24067 cells were placed in siliconized mi-C3 diluted 1/1000 (Cappel, Aurora, OH) in PBS, and blocked with
1% BSA in PBS. Fresh serum was then serially diluted in 1% BSA crocentrifuge tube (Fisher, Pittsburgh, PA) with 20 g/ml of mAb
18B7 and incubated at 37C for 1 hr. The cells were washed within PBS followed by incubation, washing, and the addition of peroxi-
dase-conjugated goat anti-mouse C3 (Cappel, Aurora, OH) diluted PBS and incubated again in the presence or absence of 100 to 200
g/ml goat anti-mouse F(ab)2 fragments specific for IgG Fc for 11/10,000. The reaction was developed by the addition of o-phenylene-
diamine (Sigma; 5 mg in 25 ml of 0.07 M citrate buffer [ph 5.0] and hr at 37C. Ab-coated yeast cells were then added to macrophages
monolayers (J774.16 or MH-S) previously treated with or without 100.01% H2O2). After the color developed, the reaction was stopped
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g/ml of Ab to CR3 (CD18 and CD11b), and the phagocytic index Scanning Electron Microscopy
C. neoformans strain 24067 cells were collected, washed with PBS,was determined as described above.
and added into a siliconized microcentrifuge tube containing
J774.16 cells activated with 50 U/ml of IFN-. Yeast cells and macro-
Studies with Transfected CHO Cells
phages were incubated for 1 hr, washed with PBS, and fixed in
Transfected CHO cells (2  104 per well) were added to 96-well
2.5% glutaraldehyde for 1 hr at RT. Samples were then applied to
plates and grown overnight in  minimal essential medium (Gibco,
a polylysine-coated coverslip and serially dehydrated in alcohol. The
Grand Island, NY). The cells were washed three times, and C. neo-
samples were fixed in a critical point drier (Samdri-790, Tousimis,
formans (4  104 per well) was added in  minimal medium without
Rockville, MD), coated with gold-palladium (Desk-1, Denton Vac-
heat-inactivated fetal serum calf in the presence or absence of 10
uum, Inc, Cherry Hill, NJ), and viewed using a JEOL JSM-6400 (JEOL
g/ml mAbs 12A1, 18B7, 7D8, and 18B7 F(ab)2 fragments. After 5 USA, Peabody, MA) instrument.
hr, unbound organisms were washed away, and the monolayer was
fixed with cold methanol for 30 min in ambient temperature and
Statistical Analysisstained with 1:20 solution of Giensa. For the CHO cell experiments,
Pairwise comparison between groups was done by the t test usingattached cells were included in the phagocytosis index since the
Primer of Statistic (McGraw-Hill, New York, NY). Regression analysisingestion process is not as efficient as for the murine macrophages.
between CR3 and percentage of macrophages with ingested yeast
was done by the ANOVA using Sigma Plot 2000 (SPSS Inc.,
Flow-Cytometric Analysis (FACS) Chicago, IL).
The presence of CR3 and CR4 on the various cell types was deter-
mined by flow cytometry. J771.16 and MH-S macrophage-like cells, Acknowledgments
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